Avinash Viswanathan

444 total citations
9 papers, 209 citations indexed

About

Avinash Viswanathan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Avinash Viswanathan has authored 9 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Avinash Viswanathan's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (4 papers) and Cancer therapeutics and mechanisms (2 papers). Avinash Viswanathan is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (4 papers) and Cancer therapeutics and mechanisms (2 papers). Avinash Viswanathan collaborates with scholars based in United States, Japan and Singapore. Avinash Viswanathan's co-authors include Ramaswamy Govindan, Feng Gao, Howard L. McLeod, C. Ryan Miller, Wan‐Teck Lim, Boone Goodgame, Bryan F. Meyers, Wei Zhang, James Watters and Alexander Patterson and has published in prestigious journals such as Journal of Clinical Oncology, Gynecologic Oncology and Journal of Thoracic Oncology.

In The Last Decade

Avinash Viswanathan

7 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Avinash Viswanathan United States	6	121	114	77	33	17	9	209
Hye-Ryoun Kim South Korea	8	137 1.1×	90 0.8×	103 1.3×	35 1.1×	11 0.6×	13	205
Wenjun Yu China	9	97 0.8×	151 1.3×	79 1.0×	98 3.0×	13 0.8×	18	268
K.H. Lee South Korea	8	206 1.7×	70 0.6×	159 2.1×	34 1.0×	6 0.4×	19	248
Lauren Carcas United States	4	54 0.4×	92 0.8×	69 0.9×	54 1.6×	42 2.5×	5	186
Mathilde Cabart France	9	127 1.0×	75 0.7×	127 1.6×	28 0.8×	32 1.9×	21	253
Daria Allina Russia	8	82 0.7×	131 1.1×	66 0.9×	93 2.8×	14 0.8×	13	248
Marzia Falanga Italy	8	84 0.7×	67 0.6×	103 1.3×	16 0.5×	27 1.6×	12	195
Shiwei Liu China	6	66 0.5×	74 0.6×	78 1.0×	69 2.1×	10 0.6×	19	173
Nur Sabrina Sapari Singapore	7	48 0.4×	110 1.0×	67 0.9×	52 1.6×	32 1.9×	15	199

Countries citing papers authored by Avinash Viswanathan

Since Specialization

Citations

This map shows the geographic impact of Avinash Viswanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avinash Viswanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avinash Viswanathan more than expected).

Fields of papers citing papers by Avinash Viswanathan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avinash Viswanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avinash Viswanathan. The network helps show where Avinash Viswanathan may publish in the future.

Co-authorship network of co-authors of Avinash Viswanathan

This figure shows the co-authorship network connecting the top 25 collaborators of Avinash Viswanathan. A scholar is included among the top collaborators of Avinash Viswanathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avinash Viswanathan. Avinash Viswanathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Viswanathan, Avinash, et al.. (2015). Comparison of FLT- and FDG-PET in gynecological cancers. Gynecologic Oncology. 137. 140–140.

2.

Goodgame, Boone, Avinash Viswanathan, Jennifer Bell Zoole, et al.. (2009). Risk of Recurrence of Resected Stage I Non-small Cell Lung Cancer in Elderly Patients as Compared with Younger Patients. Journal of Thoracic Oncology. 4(11). 1370–1374. 55 indexed citations

3.

Goodgame, Boone, Avinash Viswanathan, C. Ryan Miller, et al.. (2008). A Clinical Model to Estimate Recurrence Risk in Resected Stage I Non-Small Cell Lung Cancer. American Journal of Clinical Oncology. 31(1). 22–28. 31 indexed citations

4.

Lim, Wan‐Teck, Wei Zhang, C. Ryan Miller, et al.. (2007). PTEN and phosphorylated AKT expression and prognosis in early- and late-stage non-small cell lung cancer. Oncology Reports. 17(4). 853–7. 72 indexed citations

5.

Read, William L., Kristin Hennenfent, Sharon Marsh, et al.. (2006). A Phase II Study of Irinotecan and Carboplatin in Advanced Non-small Cell Lung Cancer with Pharmacogenomic Analysis: Final Report. Journal of Thoracic Oncology. 1(9). 972–978. 23 indexed citations

6.

Read, William L., Kristin Hennenfent, Sharon Marsh, et al.. (2006). A Phase II Study of Irinotecan and Carboplatin in Advanced Non-small Cell Lung Cancer with Pharmacogenomic Analysis: Final Report. Journal of Thoracic Oncology. 1(9). 972–978. 12 indexed citations

7.

Baggstrom, Maria Q., et al.. (2006). Barriers for accrual to clinical trials in adult patients (pts) with thoracic malignancies. Journal of Clinical Oncology. 24(18_suppl). 6058–6058.

8.

Velcheti, Vamsidhar, Avinash Viswanathan, & Ramaswamy Govindan. (2006). The Proportion of Patients with Metastatic Non-small Cell Lung Cancer Potentially Eligible for Treatment with Bevacizumab: A Single Institutional Survey. Journal of Thoracic Oncology. 1(5). 501–501. 11 indexed citations

9.

Morgensztern, Daniel, Wan‐Teck Lim, Janakiraman Subramanian, Avinash Viswanathan, & Ramaswamy Govindan. (2005). Third-line chemotherapy with gemcitabine or docetaxel in patients with advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 23(16_suppl). 7298–7298. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact